Signs, symptoms and complications of Non-Hodgkin's lymphoma according to grade and stage in South Iran

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 8, 2015, Pages 3551-3557

  Dehghani, Mehdi ^a   Haddadi, Sara ^a   Vojdani, Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Grade; Non Hodgkin's lymphoma; Signs; Stage; Symptoms

Indexed keywords

ADOLESCENT; ADULT; AGED; ANEMIA; ANOREXIA; AXILLA; B CELL LYMPHOMA; CANCER GRADING; CANCER STAGING; COHORT ANALYSIS; COMPLICATION; FEMALE; FEVER; HUMAN; INGUINAL REGION; IRAN; LYMPH NODE; LYMPHATIC DISEASES; MALE; MIDDLE AGED; NECK; NONHODGKIN LYMPHOMA; PATHOLOGY; PROSPECTIVE STUDY; SEX DIFFERENCE; T CELL LYMPHOMA; TUMOR RECURRENCE; VERY ELDERLY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANOREXIA; AXILLA; COHORT STUDIES; FEMALE; FEVER; GROIN; HUMANS; IRAN; LYMPH NODES; LYMPHATIC DISEASES; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NECK; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; SEX FACTORS; WEIGHT LOSS;

EID: 84929008488     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.8.3551     Document Type: Article

References (17)

1. Albaseri AM, El-Siddig AA, Hussainy AS, et al (2014): Pattern of lymph node pathology in western Saudi Arabia. Asian Pac J Cancer Prev, 15, 4677-81.
2. Bhattacharya B, Choudhury K, Chattopadhyay B, Mitra D (2013). Primary extranodal non-Hodgkin's lymphoma: A retrospective analysis of its clinicopathological features and treatment outcomes in a tertiary cancer center of eastern India. Clin Cancer Invest J, 2, 218.
3. Bolukbas F, Kutluturkan S (2014). Symptoms and symptom clusters in non hodgkin's lymphoma patients in Turkey. Asian Pac J Cancer Prev. 15, 7153-8.
4. Conlan MG, Bast M, Armitage JO, Weisenburger DD (1990). Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol, 8, 1163-72.
5. d'Amore F, Christensen BE, Brincker H, et al (1991). Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur J Cancer Clin Oncol, 27, 1201-8.
6. Hashemi-Bahremani M, Parwaresch MR, Tabrizchi H, et al (2007). Lymphomas in Iran. Arch Iranian Medicine, 10, 343-8.
7. Hingorjo MR, Syed S (2008). Presentation, staging and diagnosis of lymphoma: a clinical perspective. J Ayub Medical College, 20, 100-3.
8. Huff CA, Matsui W, Smith BD, Jones RJ (2006). The paradox of response and survival in cancer therapeutics. Blood, 15, 431-4.
9. Jemal A, Bray F, Center MM, et al(2011). Global cancer statistics. CA: A Cancer J Clin, 61, 69-90.
10. Johnston PB, Yuan R, Cavalli F, Witzig TE (2010). Targeted therapy in lymphoma. J Hematol Oncol, 23, 3, 45.
11. Moullet I, Salles G, Ketterer N, et al (1998). Frequency and significance of anemia in non-Hodgkin's lymphoma patients. Ann Oncol, 9, 1109-15.
12. Müller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005). Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematology, 84, 1-12.
13. Ng AK, LaCasce A, Travis LB (2011). Long-term complications of lymphoma and its treatment. J Clin Oncol, 29, 1885-92.
14. Roman E, Smith AG (2011). Epidemiology of lymphomas. Histopathology, 58, 4-14.
15. Sader-Ghorra C, Rassy M, Naderi S, et al (2014). Type distribution of lymphomas in Lebanon: five-Year single instituton experience. Asian Pac J Cancer Prev, 15, 5825-8.
16. Schwenkglenks M, Bendall KL, Pfeil AM, et al(2013). External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & lymphoma, 54, 2426-32.
17. Zelenetz AD, Abramson JS, Advani RH, et al (2011). Non-Hodgkin's lymphomas. J Natl Compr Canc Netw, 9, 484-560.